Literature DB >> 1727666

Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression.

N C Langkilde1, H Wolf, H Clausen, T Kjeldsen, T F Orntoft.   

Abstract

The T-antigen system and the mean nuclear volume have been proposed as risk variables in bladder tumors. This study includes 34 patients with initially noninvasive (Ta) transitional cell carcinomas who experienced different courses of disease. Tissue specimens of primary tumors were analyzed for the expression of T-antigen, Tn-antigen, and sialosyl-Tn-antigen using monoclonal antibodies (MoAb) and the lectin peanut agglutinin (PNA) in an indirect immunoperoxidase method. In addition, the mean nuclear volume was estimated by morphometry. Tissue from 7 of 13 patients (54%) who had invasive disease during a follow-up period of 5 years expressed T-antigen, as defined by MoAb HH8 in the primary tumor, whereas tissue of only 3 of 21 patients who did not have invasive disease expressed the antigen (P less than 0.02). No association was found between tumor progression to invasion and the expression of Tn-antigen or sialosyl-Tn-antigen. Tn-antigen expression was partially lost in invasive tumors (P less than 0.03) when compared with the expression in primary noninvasive tumors. A high mean nuclear volume in tissue specimens of primary tumors correlated with a progression to invasive disease (P less than 0.01). A significantly (P less than 0.003) higher mean nuclear volume was found in tumor areas that were positive for PNA compared with areas that were negative for PNA in primary tumors. A significantly lower mean nuclear volume was found in Tn-antigen-positive invasive Grade 3 tumor areas than in Tn-antigen-negative areas (P less than 0.005). The combined use of T-antigen expression and mean nuclear volume is of potential clinical interest for determining patients who are at high risk of disease progression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727666     DOI: 10.1002/1097-0142(19920101)69:1<219::aid-cncr2820690136>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study.

Authors:  Y Cao; P Stosiek; G F Springer; U Karsten
Journal:  Histochem Cell Biol       Date:  1996-08       Impact factor: 4.304

Review 3.  The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.

Authors:  Lu-Gang Yu
Journal:  Glycoconj J       Date:  2007-04-25       Impact factor: 2.916

4.  Keyhole limpet hemocyanin contains Gal(beta 1-3)-GalNAc determinants that are cross-reactive with the T antigen.

Authors:  I Wirguin; L Suturkova-Milosević; C Briani; N Latov
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

5.  Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.

Authors:  José Alexandre Ferreira; Paula A Videira; Luís Lima; Sofia Pereira; Mariana Silva; Mylène Carrascal; Paulo F Severino; Elisabete Fernandes; Andreia Almeida; Céu Costa; Rui Vitorino; Teresina Amaro; Maria J Oliveira; Celso A Reis; Fabio Dall'Olio; Francisco Amado; Lúcio Lara Santos
Journal:  Mol Oncol       Date:  2013-03-21       Impact factor: 6.603

6.  Establishment of new predictive markers for distant recurrence of colorectal cancer using lectin microarray analysis.

Authors:  Kentaro Nakajima; Masafumi Inomata; Hidekatsu Iha; Takahiro Hiratsuka; Tsuyoshi Etoh; Norio Shiraishi; Kenji Kashima; Seigo Kitano
Journal:  Cancer Med       Date:  2014-10-30       Impact factor: 4.452

7.  Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.

Authors:  Sofia Cotton; Rita Azevedo; Cristiana Gaiteiro; Dylan Ferreira; Luís Lima; Andreia Peixoto; Elisabete Fernandes; Manuel Neves; Diogo Neves; Teresina Amaro; Ricardo Cruz; Ana Tavares; Maria Rangel; André M N Silva; Lúcio Lara Santos; José Alexandre Ferreira
Journal:  Mol Oncol       Date:  2017-03-02       Impact factor: 6.603

Review 8.  Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

Authors:  Rita Azevedo; Andreia Peixoto; Cristiana Gaiteiro; Elisabete Fernandes; Manuel Neves; Luís Lima; Lúcio Lara Santos; José Alexandre Ferreira
Journal:  Oncotarget       Date:  2017-07-21

9.  ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.

Authors:  Paula A Videira; Manuela Correia; Nadia Malagolini; Hélio J Crespo; Dário Ligeiro; Fernando M Calais; Helder Trindade; Fabio Dall'Olio
Journal:  BMC Cancer       Date:  2009-10-07       Impact factor: 4.430

10.  Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas.

Authors:  Yanfei Xu; Sandra J Gendler; Alessandra Franco
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.